Taxpayers have footed much of the bill. About 80 percent of antipsychotic prescriptions in the U.S. are paid for by government programs, according to the National Institute of Mental Health. A group of state Medicaid directors is currently evaluating the use of the drugs in children on state Medicaid rolls, with plans to release a report in January.
